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Triacylglycerol (TAG) homeostasis is an integral part
of normal physiology and essential for proper energy
metabolism. Herewe show that the singleDrosophila
ortholog of the PXR and CAR nuclear receptors,
DHR96, plays an essential role in TAG homeostasis.
DHR96 mutants are sensitive to starvation, have
reduced levels of TAG in the fat body and midgut,
and are resistant to diet-induced obesity, while
DHR96 overexpression leads to starvation resis-
tance and increased TAG levels. We show that
DHR96 function is required in the midgut for the
breakdown of dietary fat and that it exerts this effect
through the CG5932 gastric lipase, which is essential
for TAG homeostasis. This study provides insights
into the regulation of dietary fat metabolism in
Drosophila and demonstrates that the regulation of
lipid metabolism is an ancestral function of the
PXR/CAR/DHR96 nuclear receptor subfamily.
INTRODUCTION
Fat metabolism is central to the process of energy homeostasis.
When nutrients are abundant, dietary fat in the form of triacylgly-
cerol (TAG) is broken down by gastric TAG lipases to release
fatty acids. These fatty acids are absorbed by the intestine
and used to resynthesize TAG in peripheral tissues. These
TAG reserves can be accessed upon nutrient deprivation
through the action of specific lipid droplet-associated lipases
that release the fatty acids for energy production through mito-
chondrial fatty acid b-oxidation. Defects in these processes can
lead to dramatic changes in TAG levels and a range of physio-
logical disorders, including obesity, diabetes, and cardiovas-
cular disease. The alarming rise in the prevalence of these disor-
ders in human populations has focused attention on
understanding the molecular mechanisms that coordinate die-
tary nutrient uptake with TAG homeostasis. As a result, many
regulators of TAG metabolism have been identified, including
SREBP, PPAR, and adiponectin. In spite of these advances,
however, the molecular mechanisms that coordinate dietary
fat uptake, synthesis, storage, and utilization remain poorly
understood.
Nuclear receptors (NRs) are ligand-regulated transcription
factors that play a central role in metabolic control. They are
defined by a conserved zinc-finger DNA-binding domain (DBD)Cell Mand a C-terminal ligand-binding domain (LBD) that can impart
multiple functions, including hormone binding, receptor dimer-
ization, and transactivation. Many NRs are regulated by small
lipophilic compounds that include dietary signals and metabolic
intermediates, and exert their effects by directing global
changes in gene expression that act to maintain metabolic
homeostasis. This is exemplified by members of the mammalian
PPAR, LXR, and FXR subfamilies, which play critical roles in
adipogenesis, lipid metabolism, and cholesterol and bile acid
homeostasis, respectively (Chawla et al., 2001; Sonoda et al.,
2008).
In this study we use the fruit fly, Drosophila melanogaster, as
a simple model system to characterize the NR subfamily repre-
sented by the Pregnane X Receptor (PXR, NR1I2), Constitutive
Androstane Receptor (CAR, NR1I3), and Vitamin D Receptor
(VDR, NR1I1) in mammals. Previous studies have defined central
roles for these receptors in sensing xenobiotic compounds and
directly regulating genes involved in detoxification (Timsit and
Negishi, 2007; Willson and Kliewer, 2002). Initial studies showed
that the single ancestralDrosophila ortholog of this NR subclass,
DHR96, has similar functions (King-Jones et al., 2006). A DHR96
null mutant displays increased sensitivity to the sedative effects
of phenobarbital and the pesticide DDT as well as defects in the
expression of phenobarbital-regulated genes. These studies,
however, revealed other potential roles for the receptor—in
particular, unexpected effects on the expression of genes that
are predicted to regulate lipid and carbohydrate metabolism
(King-Jones et al., 2006). This observation is in line with recent
studies that have implicated roles for the mammalian PXR and
CAR NRs in metabolic control (Moreau et al., 2008). The molec-
ular mechanism by which they exert this effect, however,
remains undefined.
Here we show thatDHR96 null mutants are sensitive to starva-
tion and have reduced levels of TAG, while DHR96 overexpres-
sion leads to starvation resistance and elevated TAG levels. A
series of studies using metabolic assays, diets, and the drug
Orlistat revealed thatDHR96mutants are defective in their ability
to break down dietary lipid. This model was supported by micro-
array studies, which showed that many genes expressed in the
midgut are misregulated in DHR96 mutants, including highly
reduced expression of the gastric lipase gene CG5932. We
show that CG5932 is required for proper whole-animal TAG
levels, and that selective expression of CG5932 in the midgut
of DHR96 mutants is sufficient to rescue their lean phenotype.
Taken together, these data support a role for the PXR/CAR/
DHR96 NR subclass in lipid metabolism and define DHR96 as
a key regulator of dietary TAG breakdown in the Drosophila
midgut.etabolism 10, 481–490, December 2, 2009 ª2009 Elsevier Inc. 481
Cell Metabolism
Drosophila DHR96 Functions in Lipid MetabolismFigure 1. DHR96 Mutants Are Sensitive to
Starvation and Display Decreased Levels
of TAG
(A) Mature adult male Canton-S (CanS) control
flies, DHR961 mutants, and the DHR962X overex-
pression strain were subjected to complete star-
vation, and the number of surviving animals was
determined at 4 hr intervals. Results are presented
as a percent of the total population, which con-
sisted of 15 groups of 20 animals for each geno-
type. Similar results were obtained in a second
independent experiment as well as from adult flies
staged at 1–2 days after eclosion.
(B and C) Total glycogen (B) and TAG (C) levels
were measured in CanS control flies, DHR961
mutants, and the DHR962X overexpression strain
under both fed conditions and after a 20 hr starva-
tion. Glycogen and TAG levels were normalized for
total protein and are presented as normalized to
a wild-type level of 100%.
(D–F) Nile red staining of dissected fat body cells
from 1- to 2-day-old adult male flies shows
reduced cell size and lipid droplet size in DHR961
mutants (E) and increased lipid droplet size in
DHR962X animals (F), relative to CanS controls (D).
(G–I) Oil red O staining of dissected adult midguts shows reduced lipid accumulation in the DHR961mutant (H) and enlarged lipid droplets in the DHR962X over-
expression strain (I), relative toCanS controls (G). The white brackets mark comparable regions of the midgut epithelium. The lumen of the midgut can be seen in
the DHR961 mutant (arrow). Scale bars are 75 mm (D–F) or 400 mm (G–I). Error bars represent ±SE, *p < 0.05 and **p < 0.001.RESULTS
DHR96 Mutants Are Lean and Sensitive to Starvation
Previous studies have shown that DHR961 null mutants, grown
under normal conditions, are viable and fertile with no apparent
developmental defects (King-Jones et al., 2006). To assess
potential metabolic roles for DHR96, we examined the ability of
mutants to survive a period of complete starvation. All studies
were performed using Canton-S wild-type flies (CanS) and
DHR961 null mutants that had been crossed to CanS through
nine generations of free recombination. Mature male flies were
collected as 5- to 7-day-old adults, transferred to starvation
media, and the number of living animals scored every 4 hours.
DHR961 mutants die at a faster rate than the wild-type controls
(Figure 1A). We also tested DHR962X animals, which carry two
transgenic copies of DHR96 along with the endogenous wild-
type locus. These flies express approximately 2-fold more
DHR96 protein than wild-type animals (M. Horner, personal
communication). The DHR962X animals are more resistant to
starvation than the wild-type controls (Figure 1A). Taken
together, these opposite effects of DHR96 loss of function and
gain of function on the starvation response suggest that this
factor plays a central role in maintaining energy homeostasis.
As a first step toward determining the basis for these effects
on the starvation response, we measured the major forms of
stored energy in the animal, glycogen and TAG levels, in control,
DHR961, and DHR962X stocks, under both fed conditions and
after 20 hr of starvation. Both the DHR961 mutant and
DHR962X animals have wild-type levels of glycogen under
normal feeding conditions (Figure 1B). The mutant, however,
has significantly less glycogen upon starvation than the wild-
type control. Interestingly, TAG levels are reduced in both fed
and starved DHR961 mutants and are elevated in both fed and482 Cell Metabolism 10, 481–490, December 2, 2009 ª2009 Elseviestarved DHR962X animals relative to controls (Figure 1C). An
2-fold reduction in TAG is also seen with a second DHR96
null allele and is effectively rescued by a wild-type genomic
DHR96 transgene (see Figure S1 available online). Taken
together, these observations suggest that the starvation sensi-
tivity of DHR96 mutants is caused by a deficit of stored energy
in the form of TAG, and implicate a central role for DHR96 in
TAG homeostasis.
To confirm and extend these results, we examined the distri-
bution of neutral lipids in the major sites of fat storage in the
animal, the fat body and midgut. Fat body cells were dissected
from 1- to 2-day-old control male flies, DHR961 mutants, and
the DHR962X overexpression strain and stained with Nile red
(Figures 1D–1F). DHR96mutant fat body cells are approximately
half the size of those in controls, with an average 3-fold reduc-
tion in lipid droplet size (Figures S2A and S2B). Conversely, fat
body cells from the DHR962X overexpression strain are wild-
type in size but have lipid droplets that are, on average, nine
times larger than those in control fat cells (Figures S2A and
S2B). Similar results were seen when the midguts of control,
DHR961 mutant, and DHR962X animals were dissected and
stained with oil red O (Figures 1G–1I). Whereas low levels of
neutral lipids can be detected in the gut epithelium of control
flies (Figure 1G), no staining is evident in the gut epithelium of
DHR961mutants (Figure 1H), and large lipid droplets are present
in the midguts of DHR962X animals (Figure 1I). These results
support our measurements of whole-animal TAG levels and indi-
cate that DHR96 plays a central role in the process of lipid
metabolism.
DHR96 Mutants Are Resistant to Diet-Induced Obesity
We next tested whether dietary conditions can alter the TAG
levels in DHR96mutant flies. Control CanS andDHR961mutantsr Inc.
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Drosophila DHR96 Functions in Lipid MetabolismFigure 2. DHR96 Mutants Are Resistant to
Diet-Induced Obesity
(A) Mature adult male Canton-S (CanS) control
flies andDHR961mutants were subjected to either
a low-calorie 0.5 SY or high-calorie 2.0 SY diet for
7 days, after which TAG levels were determined.
TAG levels were normalized for total protein and
are presented as normalized to a wild-type level
of 100%.
(B) Food uptake is slightly reduced in DHR96
mutants, as determined by scintillation counting
of Canton-S (CanS) control flies and DHR961
mutants that were maintained on food supple-
mented with 32P-dCTP.
(C) DHR96 mutants can efficiently absorb dietary
fatty acids, as determined by scintillation counting of Canton-S (CanS) control flies and DHR961 mutants that were maintained on food supplemented with
3H-oleic acid (p = 0.18).
Error bars represent ±SE, *p < 0.05 and ***p < 0.0001.were transferred to a previously characterized low-calorie
(0.5 SY) or high-calorie (2.0 SY) medium and assayed for specific
changes in TAG levels after 1 week (Mair et al., 2005). Control
flies maintained on the high-calorie diet display a significant
increase in whole-animal TAG levels relative to that seen in flies
maintained on the low calorie diet (Figure 2A). Interestingly,
DHR96 mutants grown on either the low-calorie or high-calorie
media display a lean phenotype relative to control animals on
the restrictive diet. These observations support the proposal
that DHR96 mutants are genetically lean and indicate that they
are resistant to diet-induced obesity.
It is possible that a reduced feeding rate could contribute to
the lean phenotype in DHR96 mutants. To test this possibility,
both control and DHR961 mutant flies were transferred to
medium supplemented with a radioactive dCTP tracer, and the
amount of retained label was measured after a 12 hr period (Car-
valho et al., 2005). DHR96 mutants display a mild (12%–18%)
decrease in the amount of ingested food relative to the controls
(Figure 2B). No change in food content, however, was seen upon
spectrophotometric measurement of extracts from flies grown
on yeast paste supplemented with 0.05% Bromophenol blue
(data not shown). Based on these assays, we conclude that
a reduction in feeding rate is unlikely to be a major cause of
the lean phenotype in DHR96 mutants. Similarly, there is noCell Msignificant change in the amount of radiolabeled oleic acid re-
tained inDHR96mutants after a 12 hr feeding period, suggesting
that they have no major defects in dietary fatty acid uptake
(Figure 2C).
DHR96 Mutants Are Resistant to Orlistat Treatment
We next wanted to determine if dietary TAG breakdown contrib-
utes to the lean phenotype in DHR96 mutants. As a first step
toward this goal, TAG levels were measured in control and
DHR961mutants that were maintained for 5 days on media sup-
plemented with 2 mM Orlistat (Figure 3A). Orlistat (tetrahydrolip-
statin) is a widely used over-the-counter weight loss drug (Heck
et al., 2000). It acts inside the intestine as a competitive inhibitor
of pancreatic and gastric lipases, preventing their interaction
with dietary TAG and thus blocking fatty acid release and dietary
lipid uptake. Control flies exposed to Orlistat display a significant
reduction in fat levels (Figure 3A). A similar effect was seen in
mutants for the fly perilipin homolog Lsd-2, which are lean due
to reduced levels of fat body TAG, consistent with the conclusion
that Orlistat specifically inhibits Drosophila gastric lipases
(Gro¨nke et al., 2003) (Figure S3A). In contrast, no effect was
seen upon exposing DHR96 mutants to the drug. These obser-
vations were confirmed by staining midguts dissected from
either untreated or Orlistat-treated control and DHR961 mutantsFigure 3. DHR96 Mutants Are Resistant to
Treatment with Orlistat
(A) Mature adult male Canton-S (CanS) control
flies and DHR961 mutants were transferred to
a diet either with or without 2.0 mM Orlistat for
5–7 days, after which TAG levels were determined.
TAG levels were normalized for total protein and
are presented as normalized to a wild-type level
of 100%. Error bars represent ±SE, ***p < 0.0001.
(B–E) Oil red O staining of dissected adult midguts
shows that lipid accumulation is significantly
reduced in CanS flies fed Orlistat (C), relative to
controls (B) and undetectable in DHR961 mutants
maintained on either normal food (D) or food sup-
plemented with Orlistat (E). Low levels of lipids can
be detected in the midgut lumen of DHR96
mutants and CanS flies fed Orlistat (arrows). Scale
bars are 400 mm.etabolism 10, 481–490, December 2, 2009 ª2009 Elsevier Inc. 483
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Drosophila DHR96 Functions in Lipid Metabolismwith oil red O (Figures 3B–3E). Control flies maintained on the
high-nutrient diet used for this study display clearly detectable
levels of neutral lipids in their gut epithelium, and this level is
significantly reduced in the midguts of animals exposed to Orli-
stat (Figures 3B and 3C). In contrast, DHR96 mutants display
no detectable neutral lipids in their midguts, either in the pres-
ence or the absence of drug (Figures 3D and 3E). These results
raise the possibility that the lean phenotype in DHR96 mutants
may arise, at least in part, from decreased TAG lipase activity
in the midgut.
DHR96 Functions in the Midgut to Control the
Breakdown of Dietary TAG
To test the possibility that DHR96 mutants have a decreased
ability to break down dietary fat, lysates were prepared from
dissected control CanS and DHR961 mutant midguts and as-
sayed for TAG lipase activity by examining their ability to cleave
a glycerol tributyrate substrate. This experiment showed that
lysates from DHR96 mutants have significantly reduced lipase
activity relative to lysates from control animals, suggesting that
decreased gastric lipase activity is a primary cause of the lean
phenotype in DHR96 mutants (Figure 4A). To further test this
model, we attempted to bypass the need for midgut lipolysis
by rescuing the lean phenotype through dietary supplementation
with free fatty acids. ControlCanS andDHR961mutant flies were
transferred to a lipid-depleted medium that was either unsupple-
mented with lipid or supplemented with a mixture of stearic acid
and oleic acid (free fatty acids) or a mixture of glycerol tristearate
and glycerol trioleate (TAG). Extracts were prepared from these
animals after 7 days and assayed for TAG levels (Figure 4B).
As expected, DHR96 mutants maintained on the lipid-depleted
medium continue to display the lean phenotype. Interestingly,
the same phenotype is seen when DHR96 mutants are main-
tained in the presence of supplemented TAG, while the lean
phenotype is effectively rescued by dietary supplementation
with free fatty acids (Figure 4B). This observation indicates that
an inability to break down dietary TAG is a major contributing
factor to the lean phenotype seen in DHR96 mutants. Phospho-
lipid digestion, however, appears to be normal in DHR96
mutants, as revealed by cleavage of the quenched fluorescent
phospholipid PED6, which provides an accurate indicator of
gastric phospholipase activity (data not shown) (Farber et al.,
2001).
Expression of wild-type DHR96 effectively rescues the lean
phenotype of DHR96 mutants, indicating that this phenotype
can be attributed to a specific defect in DHR96 function
(Figure S1). If, however, DHR96 regulates the breakdown of die-
tary fat, then we should be able to rescue themutant lean pheno-
type by specifically expressing the wild-type receptor in the
midgut of DHR96 mutants. Consistent with this proposal,
specific expression of wild-type DHR96 in the fat body of
DHR96 mutants does not have a significant effect on the low
levels of TAG seen in these animals, while specific expression
of wild-type DHR96 in the midgut of DHR96 mutants effectively
rescues the lean phenotype (Figure 4C). This observation indi-
cates that the reduced levels of TAG seen in DHR96 mutants
arise from defects in midgut function. Taken together with our
dietary rescue experiments, we conclude that DHR96 plays
a central role in controlling the breakdown of dietary fat.484 Cell Metabolism 10, 481–490, December 2, 2009 ª2009 ElsevieDHR96 Regulates Genes Expressed in the Midgut and
Involved in Metabolism
Microarray studies were conducted to determine the molecular
mechanisms by which DHR96 regulates lipid homeostasis.
Figure 4. DHR96 Functions in the Midgut to Control Dietary TAG
Breakdown
(A) Midguts dissected from mature adult male Canton-S (CanS) control flies
and DHR961 mutants were homogenized, and increasing amounts of lysate
were tested for TAG lipolytic activity by assaying for the release of glycerol
from a glycerol tributyrate emulsion.
(B) Mature adult maleCanton-S (CanS) control flies andDHR961mutants were
transferred to lipid extracted 1.0 SY medium alone (lipid), medium supple-
mented with TAG (+TAG), or medium supplemented with free fatty acids
(+FFA) for 7 days, after which TAG levels were determined. TAG levels were
normalized for total protein and are presented as normalized to a level of
100% in CanS flies on the unsupplemented lipid-extracted medium.
(C) Tissue-specific expression of a wild-type UAS-DHR96 transgene in the
midgut of DHR96 mutants, driven by Mex-GAL4 (Mex > DHR96), is sufficient
to rescue the lean phenotype. In contrast, little effect is seen when Cg-GAL4
is used to drive fat body-specific expression of the UAS-DHR96 transgene
(Cg > DHR96). The presence of the GAL4 drivers alone or the UAS-DHR96
transgene in the DHR96 mutant background has no effect on TAG levels
(data not shown). Error bars represent ±SE, ***p < 0.0001.r Inc.
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Drosophila DHR96 Functions in Lipid MetabolismThis study revealed that 136 genes are significantly affected by
the DHR96 mutation in fed adult flies, with 94 genes displaying
increased levels of expression and 42 genes showing decreased
levels of expression (Table S1). A significant number of genes
involved in cuticular structure and the peritrophic matrix, which
acts as protective layer inside the lumen of the midgut, are upre-
gulated in the mutant, while many genes that encode predicted
a-mannosidases and endopeptidases are expressed at lower
levels. Genesmore directly involved inmetabolism are also over-
represented in the list of DHR96-regulated genes. These include
two genes that encode larval serum proteins: Lsp1g (+2.2-fold in
the DHR96 mutant) and Lsp2 (+3.1-fold). These proteins are
synthesized by the fat body and are thought to provide a source
of amino acids to support adult development during metamor-
phosis (Telfer and Kunkel, 1991). Interestingly, the gene that
encodes the larval serum protein receptor, Fbp1 (+3.1-fold), is
also regulated by DHR96, suggesting a central role for DHR96
in LSP function (Burmester et al., 1999).Mdr50, which is reduced
in its expression inDHR96mutants (1.5-fold), is the fly ortholog
of mammalian ATP-binding cassette subfamily B, member 4
(ABCB4), a protein that is primarily expressed in the liver and
involved in phospholipid transport. Similarly, the fifth most
downregulated gene in DHR96 mutants, CG13325, encodes
a protein with a predicted acyltransferase domain that could
function in lipid transport. Finally, it is remarkable that the most
significantly affected genes in DHR96 mutants include most of
the Drosophila orthologs of the Niemann-Pick (NPC) disease
genes that play central roles in cholesterol metabolism, including
npc1b (+2.6-fold up) and five NPC2 family members: npc2c
(+1.7-fold); npc2d (13-fold); npc2e (+21-fold); and two genes
that are below our 1.5-fold cutoff in expression level, npc2g
and npc2h (both 1.4-fold).
Closer examination of the DHR96-regulated genes reveals
that many are expressed exclusively, or most abundantly, in
the midgut. Of the 132 genes that are misregulated in DHR96
mutants, 42 are included in the 2695midgut-specific genes iden-
tified by Li et al. (2008) (32%; p value = 93 109). A similar over-
representation of midgut-expressed genes can be seen by
surveying the expression patterns on FlyAtlas (Chintapalli
et al., 2007). For example, 12 of the 15 most downregulated
genes, and 9 of the 15 most upregulated genes in DHR96
mutants, are highly expressed in the midgut (Figure S4).
Finally, we found that many of theDHR96-regulated genes are
located next to one another in the genome. The gene clusters
include three genes with predicted a-mannosidase activity,
CG9463 (3.3-fold), CG9466 (5.9-fold), and CG9468 (4.3-
fold), all of which are among the most highly downregulated
genes in the mutant. A divergently transcribed pair of genes
with predicted a-mannosidase activity are also misregulated in
DHR96 mutants, CG5322 (1.3-fold) and CG6206 (1.8-fold),
as well as two genes with predicted a-glucosidase activity,
CG14934 (+1.5-fold) and CG14935 (1.6-fold), and a cluster of
two Jonah genes that encode predicted gastric peptidases,
Jon65Ai and Jon65Aii (both 1.7-fold). Two genes with pre-
dicted sphingomyelin phosphodiesterase activity, CG15533
(+2.0-fold) and CG15534 (+1.3-fold), are regulated by DHR96.
Moreover, many of the NPC genes that are misregulated in
DHR96 mutants lie within gene clusters. These include npc2d
(13-fold), npc2e (+21-fold), and npc2c (+1.7-fold). An adjacentCell Mgene, fancl, which has no known function, is downregulated 1.5-
fold inDHR96mutants. In addition, npc2g and npc2h are located
next to one another in the genome.
DHR96 Regulates the CG5932 Gastric Lipase to
Promote TAG Accumulation
Two genes that encode predicted TAG lipases were identified in
our microarray study of DHR96mutants, CG5932 and CG31091
(Table S1). Both genes encode members of the a/b-hydrolase
fold lipase family and are homologs of human gastric lipases,
with 37% and 33% amino acid identity, respectively. In addition,
both genes are expressed almost exclusively in the larval and
adult midgut (Chintapalli et al., 2007), raising the possibility that
their misexpression may contribute to the reduced ability of
DHR96 mutants to break down dietary TAG. Validation of the
effects of theDHR96mutation onCG5932 andCG31091 expres-
sion by northern blot hybridization showed that CG31091mRNA
levels are very low, consistent with the CG31091 expression
levels reported on FlyAtlas (Chintapalli et al., 2007) (data not
shown). In contrast, CG5932 is abundantly expressed and is
downregulated by starvation in wild-type flies (Figure 5A, lanes
1 and 3), and this expression is significantly reduced in fed or
starved DHR96 mutants (Figure 5A, lanes 2 and 4). CG5932 is
also the fourth most highly downregulated gene identified in
our microarray study. Chromatin immunoprecipitation of
DHR96 protein from wild-type lysates revealed direct binding
to sequences immediately upstream from CG5932 (Figure S5).
This binding is not seen at a promoter that is independent of
DHR96 regulation or in chromatin immunoprecipitation experi-
ments using lysates made from DHR96 mutants, suggesting
that it represents a specific DNA-protein interaction. Moreover,
expression of wild-type DHR96 in the midgut of DHR96mutants
is sufficient to restore normal CG5932 expression (data not
shown). Taken together, these observations suggest that
DHR96 maintains TAG homeostasis through direct regulation
of CG5932 expression.
If CG5932 is essential for TAG homeostasis, then disruption of
CG5932 function should lead to changes in TAG levels. To test
this possibility, we used Act-GAL4 to drive the expression of
a UAS-CG5932 RNAi construct. Whereas flies that carry either
the Act-GAL4 driver alone or the UAS-CG5932 RNAi construct
alone display normal levels of TAG and CG5932 expression,
combining Act-GAL4 with the UAS-CG5932 RNAi construct re-
sulted in significant reduction of both whole-animal TAG levels
and CG5932 mRNA accumulation (Figure 5B). Similar results
were seen upon driving UAS-CG5932 RNAi with the midgut-
specific Mex-GAL4 driver (Figure S6A). These animals are also
sensitive to starvation, consistent with their lean phenotype
(Figure S6B). In addition, purified CG5932 protein has lipolytic
activity in vitro, as demonstrated by its ability to break down
a glycerol tributyrate substrate (Figure S7). Taken together, these
observations indicate that CG5932 plays a critical role in the
midgut to regulate whole-animal TAG homeostasis, most likely
through its effect on the breakdown of dietary fat.
If the downregulation of CG5932 expression in DHR96
mutants contributes to their inability to break down dietary
TAG, then restoring CG5932 expression specifically in the
midgut of these animals should rescue their lean phenotype.
To test this possibility, we established transformant lines thatetabolism 10, 481–490, December 2, 2009 ª2009 Elsevier Inc. 485
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Drosophila DHR96 Functions in Lipid Metabolismcarry two different insertions of a UAS-CG5932 transgene. As
expected, the presence of either the midgut-specific Mex-Gal4
driver alone or each UAS-CG5932 transgene had little or no
effect on the reduced TAG levels seen in the DHR96 mutant
(Figure 6). Combining the Mex-GAL4 driver with either of the
UAS-CG5932 transgenes in a DHR96 mutant, however, allows
themutant to recover normal levels of TAG (Figure 6). In addition,
overexpression of CG5932 does not stimulate an increase in
whole-animal TAG levels, indicating that while CG5932 is neces-
sary for TAG homeostasis, it is not sufficient to drive TAG accu-
mulation (Figure S8). These results, combined with our observa-
tion that the lean phenotype in DHR96 mutants can be rescued
by dietary supplementation with free fatty acids (Figure 4B),
and the absence of an effect of Orlistat treatment in DHR96
mutants (Figure 3A) or Act > CG5932 RNAi animals (Figure S3B),
suggests that DHR96 controls whole-animal TAG levels through
its regulation of the CG5932 gastric lipase.
DISCUSSION
Recent studies have implicated roles for mammalian PXR and
CAR in controlling lipid metabolism, although little is known
Figure 5. DHR96 Regulates the CG5932 Gastric Lipase Gene to
Control the Breakdown of Dietary TAG
(A) RNA was isolated from either fed or starved CanS control flies (+ DHR96)
and DHR961 mutants ( DHR96) and analyzed by northern blot hybridization
for CG5932 transcription. Hybridization to detect rp49 mRNA was used as
a control for loading and transfer.
(B) An Act-GAL4 driver or the UAS-CG5932 RNAi transgene alone have no
effect on whole-animal TAG levels (above) or CG5932 mRNA levels (below),
as determinedbynorthern blot hybridization.Combining these two transgenes,
however, effectively reduces CG5932 expression and leads to a significant
reduction in total TAG levels. Hybridization to detect rp49 mRNA was used
as a control for loading and transfer. Error bars represent ±SE, ***p < 0.0001.486 Cell Metabolism 10, 481–490, December 2, 2009 ª2009 Elsevieregarding the molecular mechanisms by which they exert these
effects. Here we show that the singleDrosophila ortholog of PXR
and CAR, DHR96, plays an essential role in maintaining whole-
animal TAG levels through the proper breakdown of dietary fat.
Our results indicate that DHR96 acts through a previously un-
characterized gastric lipase encoded by CG5932 to promote
dietary lipid uptake and maintain TAG homeostasis.
DHR96 Mutants Are Sensitive to Starvation
Due to Decreased Levels of TAG
Although DHR96 null mutants are viable and fertile, with no
morphological defects, they die significantly more rapidly than
genetically matched control flies under starvation conditions,
while DHR96 overexpression leads to starvation resistance
(Figure 1A). The effects of these genotypes on the major forms
of stored energy in the animal, glycogen and TAG, are consistent
with their effects on the starvation response. DHR96 mutants
have reduced levels of TAG under both fed and starved condi-
tions, while DHR96 overexpression leads to increased TAG
levels (Figure 1C). Although no effects are seen on whole-animal
glycogen levels in fed animals that either lack or overexpress
DHR96, the mutants consume significantly more glycogen
upon starvation than do controls (Figure 1B). This rapid utilization
of glycogen stores is most likely due to the decreased energy
contribution from TAG. Taken together, these observations
suggest that the starvation sensitivity of DHR96 mutants can
be attributed to their lean phenotype, while the starvation resis-
tance of the DHR962X strain is due to their excess energy in the
form of TAG. This proposal is supported by the observation that
genetically elevating the levels of TAG in DHR96 mutants by
introducing mutations in bmm or AKHR, which control distinct
aspects of fat body TAG lipolysis (Gro¨nke et al., 2007), effectively
Figure 6. Midgut-Specific Expression of CG5932 Rescues the Lean
Phenotype of DHR96 Mutants
TAG levels were determined inmature adult maleCanton-S (CanS) control flies
or DHR961 mutants that carried different transgenes. Either the midgut-
specific Mex-GAL4 driver alone or two different insertions of the UAS-
CG5932 rescue transgene alone (UAS-CG59321 or UAS-CG59322) had little
or no effect on whole-animal TAG levels. The increased level of TAG seen in
the presence of UAS-CG59322 alone could be due to background expression
from a flanking regulatory element, as is often seen with P element insertions.
In contrast, combining the Mex-GAL4 driver with each UAS-CG5932 rescue
transgene restored normal TAG levels. TAG levels were normalized for total
protein and are presented as normalized to a wild-type level of 100%. Error
bars represent ±SE, **p < 0.001 and ***p < 0.0001.r Inc.
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opposite effects of DHR96 loss of function and gain of function
on both the starvation response and TAG levels argue that this
receptor plays a central role in maintaining whole-animal TAG
homeostasis.
DHR96 Functions in the Midgut to Regulate the Uptake
of Dietary Nutrients
Several lines of evidence support the conclusion that DHR96
exerts its primary metabolic functions through themidgut. These
include our initial observation that DHR96 mutants are resistant
to treatment with the gastric lipase inhibitor Orlistat (Figure 3)
and display reduced levels of midgut lipolytic activity
(Figure 4A). In addition, dietary supplementation with free fatty
acids, but not TAG, is sufficient to rescue the lean phenotype
of DHR96 mutants, as is midgut-specific expression of wild-
type DHR96 in a DHR96 mutant background (Figure 4C). We
also see a dramatic effect on lipid levels in the midgut, where
almost no neutral lipids are detectable in DHR96 mutants and
enlarged lipid droplets are evident in DHR962X flies maintained
on a normal diet (Figures 1H and 1I). Interestingly, while the
lumen of the midgut is not evident in control animals, we clearly
see material in the lumen of DHR96mutant midguts or in control
flies that are treated with Orlistat (Figures 1H and 3C–3E). In
some cases, this material is stained by oil red O, suggesting
that it may represent an increased level of undigested fat in these
animals. This phenotype would be similar to that seen in humans
who have defects in intestinal lipase activity (Ligumsky et al.,
1990). Likewise, an increase in the passage of undigested dietary
fat is a complication associated with Orlistat treatment in
patients (Heck et al., 2000). Taken together, these observations
support the conclusion thatDHR96 acts in themidgut to regulate
the breakdown of dietary fat.
An essential role for DHR96 in the midgut is further supported
by our microarray study, which revealed that manyDHR96-regu-
lated genes are primarily expressed in this tissue. Interestingly,
many of these genes have predicted roles related to the break-
down of dietary nutrients (Table S1). These include downregula-
tion of multiple genes with predicted a-mannosidase activity,
which is involved in the breakdown of the complex sugars found
on glycoproteins. Many genes that encode trypsins and endo-
peptidases are also expressed at reduced levels in DHR96
mutants as well as a few genes that encode predicted a-gluco-
sidases, which are involved in the breakdown of dietary carbohy-
drates. In addition, a number of genes involved in the formation
of the peritrophic matrix are more abundantly expressed in
DHR96 mutants. This matrix is comprised of chitin and peritro-
phic proteins and acts as a protective layer for the epithelial
surface of the midgut (Hegedus et al., 2009). The peritrophic
matrix also has critical roles in facilitating digestion. Only smaller
molecules that arise from the initial digestion of complex nutri-
ents, including peptides, sugars, and lipids, can move through
the peritrophic matrix for final digestion and absorption by the
midgut epithelium. These events are controlled by the selective
partitioning of digestive enzymes to different sides of the peritro-
phic matrix as well as within the matrix itself. Thus, while midgut
morphology appears normal in DHR96mutants, the effect of the
mutation on the peritrophic matrix could impact nutrient diges-
tion and absorption.Cell MIn addition to genes that regulate different aspects of lipid
metabolism, our microarray study of DHR96 mutants identified
widespread effects on the expression of Drosophila homologs
of NPC disease genes. The npc1b gene, which encodes an
essential cholesterol transporter and the ortholog of mammalian
NPC1L1 (Voght et al., 2007), is the tenth most highly upregulated
gene in DHR96 mutants. In addition, five of the eight Drosophila
NPC2 genes are misregulated inDHR96mutants: npc2c, npc2d,
npc2e, npc2g, and npc2h (Huang et al., 2007). These genes
encode homologs of mammalian NPC2, which is involved in
intracellular cholesterol trafficking (Huang et al., 2007). Remark-
ably, two of these genes are the most highly up- and downregu-
lated genes identified in the mutant (npc2e and npc2d, respec-
tively; Table S1). Moreover, many of these npc genes are
located in clusters, suggesting that they are coregulated by the
receptor. Although the function of these npc2 genes is unknown,
their disproportionate representation within the list of DHR96-
regulated genes implies a critical role for the receptor in regu-
lating cholesterol trafficking. Indeed, dietary cholesterol triggers
a widespread transcriptional response in Drosophila that is
dependent on DHR96 function (Horner et al., 2009). Moreover,
this study showed that DHR96 mutants display defects in their
ability to maintain cholesterol homeostasis when grown on
a high-cholesterol diet. Taken together with the results pre-
sented here, our studies suggest that DHR96 plays an essential
role in the midgut to coordinate the processes of TAG and
cholesterol breakdown, absorption, and trafficking.
DHR96 Regulates CG5932 to Control the Breakdown
of Dietary TAG
Two genes with predicted TAG lipase activity are expressed at
lower levels in DHR96 mutants (Table S1). One of these genes,
CG5932, is abundantly expressed in the larval and adult midgut,
encodes a protein that is highly related to human gastric lipase
(LIPF, 37% identity over 358 amino acids), and is essential for
maintaining whole-animal TAG levels (Figure 5). In addition,
restoring CG5932 expression in the midguts of DHR96 mutants
is sufficient to rescue their lean phenotype, defining this gene
as a critical functional target of the receptor (Figure 6). Interest-
ingly, CG5932 expression is also regulated by starvation, with
reduced expression in the absence of food and increased
expression upon refeeding (Figure 5A) (Gershman et al., 2006).
This regulation is consistent with an essential role for CG5932
in the breakdown of dietary fat, where its expression is upregu-
lated when food is present. This response, however, is unaf-
fected in DHR96mutants, indicating that it is under independent
control, possibly by known regulators of the starvation response
such as dFOXO (Gershman et al., 2006).
The identification of CG5932 as a key functional target of
DHR96 raises the question of how that regulation is achieved.
We have tested a range of dietary parameters and candidate
ligands using the GAL4-DHR96 ligand sensor but have been
unable to identify conditions that activate the DHR96 LBD (Pal-
anker et al., 2006). In addition, the DHR96-binding site remains
undefined. DHR96 has a unique P box sequence within its
DBD, which determines its DNA-binding specificity. This
sequence is only shared by three C. elegans NRs, DAF-12,
NHR-48, and NHR-8. Consistent with this observation, we found
that DHR96 protein fails to bind to most canonical NR-bindingetabolism 10, 481–490, December 2, 2009 ª2009 Elsevier Inc. 487
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element (Fisk and Thummel, 1995). One study has shown that
DAF-12 displays preferential binding to a direct repeat of two
distinct hexanucleotide sequences (AGGACA and AGTGCA),
separated by five nucleotides (DR5) (Shostak et al., 2004).
Whether DAF-12 contacts these sequences as a homodimer or
a heterodimer with another NR, however, remains to be deter-
mined. The observation that many DHR96-regulated genes are
arranged in clusters and DHR96 binds directly to a region
upstream from the CG5932 start site provides an ideal context
for defining its DNA-binding specificity as well as determining
the molecular mechanisms by which DHR96 coordinates target
gene transcription.
DHR96 May Indirectly Regulate Xenobiotic Responses
in Drosophila
Our studies of DHR96 raise the interesting possibility that the
defects in xenobiotic detoxification seen in DHR96 mutants
may arise, at least in part, from its role in regulating midgut meta-
bolic activity. As noted in our original study, most of the genes
that are regulated by phenobarbital in wild-type flies do so inde-
pendently of DHR96 (King-Jones et al., 2006). These genes
include representatives of the major classes associated with
xenobiotic detoxification: cytochrome P450 monooxygenases
(P450s), glutathione S-transferases (GSTs), carboxylesterases,
and UDP-glucuronosyl transferases (UGTs). Moreover, some
phenobarbital-regulated genes that are misregulated in DHR96
mutants still show a transcriptional response to the drug,
although that response is muted. These observations indicate
that one or more other factors contribute to the transcriptional
response to xenobiotic challenge in Drosophila. Interestingly,
similar results have been observed in vertebrates, where less
then half of the genes that are regulated by xenobiotics are
affected in PXR and CAR mutant mice (Maglich et al., 2002;
Ueda et al., 2002). It remains unclear, however, whether this
lack of regulation might be due to functional redundancy
between these mammalian receptors.
There are several possible mechanisms by which the meta-
bolic functions of DHR96 could impact xenobiotic responses.
First, a recent study of the expression patterns of Drosophila
P450 genes showed that 34 of 60 genes that could be detected
in third-instar larvae are expressed in the midgut or hindgut
(Chung et al., 2009). A similar overrepresentation of P450 genes
is evident in a microarray study of midgut expressed genes
(Li et al., 2008). These observations indicate that, contrary to
previous assumptions, the gut, and not the fat body, may be
a critical site for xenobiotic detoxification (Chung et al., 2009).
If this is true, then the sensitivity of DHR96mutants to phenobar-
bital or DDT treatment may be affected by the effects of this
mutation on midgut physiology. This could occur through
defects in the peritrophic matrix or through changes in the ability
of themidgut to absorb lipophilic xenobiotic compounds such as
DDT. An alternative possibility is that the sensitivity of DHR96
mutants to xenobiotics might be due to their decreased energy
stores. Detoxification requires energy expenditure. For example,
P450s consume NADPH or NADH for their oxidation of xenobi-
otics, UGTs consume glucose, and GSTs consume glutathione.
Thus, the reduced levels of stored energy in DHR96 mutants
might compromise their ability to properly inactivate toxic488 Cell Metabolism 10, 481–490, December 2, 2009 ª2009 Elseviecompounds. In addition, the reduced lipid stores in DHR96
mutants might exert an indirect effect on xenobiotic responses
by lowering the ability of the animal to sequester toxins in the
fat reserves of the animal. Thus, there are multiple pathways
by which the midgut-specific metabolic defects associated
with the DHR96 mutation might indirectly affect xenobiotic
responses in these animals. Further studies are required to test
this possibility and clarify the functional overlaps between the
roles ofDHR96 in lipidmetabolism and xenobiotic detoxification.
Conserved Roles for the PXR/CAR/DHR96 Nuclear
Receptors in Lipid Metabolism
Several recent studies have demonstrated roles for both PXR
and CAR in lipid metabolism (Moreau et al., 2008). CAR can
repress the transcription of genes encoding carnitine palmitoyl-
transferase and enoyl-CoA isomerase, key steps in lipid b-oxida-
tion (Ueda et al., 2002). CAR mutant mice are also sensitive to
starvation, much as we observe for DHR96 mutants, and lose
weight more rapidly than wild-type mice when maintained on
a low-calorie diet (Maglich et al., 2004). Transgenic expression
of a constitutively active form of PXR in the mouse liver leads
to hepatic steatosis along with reduced expression of lipid cata-
bolic genes and increased expression of genes involved in lipid
synthesis (Zhou et al., 2006). Importantly, similar effects were
observed upon pharmacological activation of PXR using
a specific agonist, indicating that the endogenous receptor can
contribute to lipid homeostasis (Hoekstra et al., 2009; Nakamura
et al., 2007). Most recently, amutation inCAR has been shown to
normalize the elevated serum TAG levels seen in leptin-deficient
mice or in wild-type mice maintained on a high-fat diet (Maglich
et al., 2009). Conversely, treatment of wild-type mice with
a selective CAR agonist leads to increased serum TAG levels,
and this response fails to occur in a CAR mutant background.
Taken together, these studies indicate that activation of
PXR/CAR receptors leads to lipid accumulation while a loss of
PXR/CAR activity leads to reduced lipid levels, defining a central
role for these NRs in lipid homeostasis. Their role in normal lipid
metabolism, however, remains unknown, although it may be
masked by functional redundancy between the two receptors.
Similarly, the molecular mechanisms by which PXR and CAR
can modulate lipid levels remain to be defined.
Our genetic studies of DHR96 demonstrate that these meta-
bolic activities of PXR and CAR have been conserved through
evolution, and represent an essential ancestral function for this
NR subfamily. Moreover, the observation that DHR96 overex-
pression leads to lipid accumulation and DHR96 mutants are
lean suggests that themolecular mechanisms that underlie these
effects are also conserved across species. This conclusion is
supported by genetic studies of the C. elegans member of this
subfamily, DAF-12, which indicate that this receptor is also
required for proper levels of stored fat (Gerisch et al., 2001).
Our study provides further evidence of a role for this NR
subfamily in normal lipid homeostasis and defines the control
of dietary fat breakdown as a key step at which this regulation
is achieved. In addition, this work provides a foundation for
understanding how dietary lipid uptake can impact normal lipid
metabolism inDrosophila and provides a genetic model for char-
acterizing how dietary factors can lead to lipid metabolic disor-
ders such as obesity.r Inc.
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Fly Stocks
The following stocks were used in this study:DHR961 (King-Jones et al., 2006),
Cg-Gal4 (Hennig et al., 2006), Mex-Gal4 (Phillips and Thomas, 2006), Act-
Gal4/CyO (Bloomington # 25374), bmm1 (Gro¨nke et al., 2005), AKHR2 (Gro¨nke
et al., 2007), Lsd-2KG00149 (Gro¨nke et al., 2003), w1118, DHR962X (M. Horner,
personal communication), UAS-DHR96 (M. Horner, personal communication),
and UAS-CG5932 RNAi (National Institute of Genetics stock 5932R-3). Flies
were maintained on standard Bloomington Stock Center medium with malt
at 25C. The UAS-CG5932 P element construct was made using oligonucleo-
tide primers 50-ATAGAATTCATGAATCCAATCTTCTGCGC-30 and 50- ATACTC
GAGCTAGCGACCTTCGTAGGAGT-30 to amplify the CG5932 cDNA (Gen-
Bank NM_140972) from the DGRC LP10120 cDNA clone by PCR. Following
digestion with EcoRI and XhoI, the cDNA was inserted into the corresponding
sites of the pUAST vector. This UAS-CG5932 construct was then integrated
into the w1118 genome.
Metabolic Assays
All studies used 1- to 2-day-old adult male flies that were aged 5–7 days prior
to the experiment. Starvation sensitivity assays were conducted by transfer-
ring 15 samples of 20 flies of each genotype into vials containing 1% agar.
Mortality was assayed every 4 hr as determined by a lack of responsiveness
to touch. For glycogen and TAG assays, five to ten mature adult male flies
were homogenized in 100–200 ml PBST (PBS, 0.1% Tween 20), heated at
70C for 5 min to inactivate endogenous enzymes, and the homogenate
cleared by centrifugation for 3 min. The supernatant was diluted 1:4 with
PBST and assayed for glycogen levels as described (Palanker et al., 2009).
TAG assays were conducted as described (Palanker et al., 2009), using the
Stanbio triglyceride liquicolor kit (2100-430). The glycogen and TAG levels in
each sample were normalized for total protein as determined by a Bradford
assay. Both glycogen and TAG data were compiled from six samples collected
from each genotype under each condition. All data are presented as normal-
ized to a wild-type level of 100%. All assays were repeated three times, and
a representative experiment is presented in each figure. Nile red staining
was performed as described by Gro¨nke et al. (2005), using Nile red mounting
media (20% glycerol in PBS, with a 1:10,000 dilution of 10%Nile red in DMSO)
and imaged on a Leica TCS SP2 confocal microscope using an excitation
wavelength of 543 nm and a 600–650 nm emission spectrum. For oil red
O stains, midguts frommature adult flies were dissected and fixed in 4% para-
formaldehyde/PBS for 20 min. The midguts were washed with distilled water
and incubated in 100% propylene glycol for 5 min. Specimens were then incu-
bated at 60C in oil red O stain (0.5% oil red O in propylene glycol), washed
twice with propylene glycol, washed three times with PBS, and mounted in
20% glycerol/PBS for imaging.
Dietary Treatments
All studies used 1- to 2-day-old adult male flies that were aged 5–7 days prior
to the experiment. Diet-induced obesity was assayed by transferring flies to
either a low-calorie 0.5 SY diet or a high-calorie 2.0 SY diet for 7 days, after
which extracts were prepared and assayed for TAG and protein (Mair et al.,
2005). Food intake was measured by transferring flies to Bloomington corn-
meal, yeast, and molasses medium supplemented with 0.1 mC/ml 32P-dCTP
(Perkin-Elmer) for 12 hr, after which they were transferred to normal unlabeled
food for 4 hr to remove label that was nonspecifically bound to the outside of
the animal (Carvalho et al., 2005). Ten to twelve groups of 20 flies were
collected, washed once with 0.1% BSA, and assayed for label retention on
a scintillation counter. Fatty acid uptake was determined in a similar manner,
using 3H-oleic acid (Moravek Biochemicals) at a final concentration of 3 mC/ml.
Treatment with Orlistat was conducted by growing flies on a high-nutrient
molasses medium (Bloomington cornmeal, yeast, and molasses media) with
or without 2 mMOrlistat for 5–7 days. TAG levels were then assayed as above.
All data shown are from two parallel data sets of six samples/stock/condition
compiled together and repeated at least three times. Dietary lipid supplemen-
tation was performed by transferring mature adult males to lipid-depleted
1.0 SY for 5–7 days. This mediumwas prepared by extracting the yeast extract
and agar components of the SY medium overnight with chloroform, followed
by a second 4 hr chloroform extraction. Both components were then allowedCell Mto dry for 2–3 days in a fume hood. The lipid-depleted medium was supple-
mented with either free fatty acids (5 mg/ml stearic acid and 5 mg/ml oleic
acid, ChemService) or TAG (5 mg/ml glycerol tristearate and 5 mg/ml glycerol
trioleate, ChemService). All data shown are from two collections of six samples
collected from each genotype under each condition. Each experiment was
repeated at least three times.
Microarrays
Adult male CanS and DHR961 flies were collected 1–2 days after eclosion and
allowed to age for 7 days on normal medium. RNA was extracted from these
animals using Trizol (GIBCO) and purified on RNAeasy columns (QIAGEN).
All samples were prepared in triplicate to facilitate subsequent statistical anal-
ysis. Probe labeling, hybridization to Affymetrix GeneChipDrosophilaGenome
2.0 Arrays, and scanning were performed by the University of Maryland Micro-
array Core Facility. Raw data were subjected to quantile normalization using
R statistical analysis software, and gene expression changes were determined
using SAM 2.0, with a <5%estimated false positive rate and a 1.5-fold cutoff in
expression level (Tusher et al., 2001). Comparison between microarray data
sets was performed using Microsoft Access.
Statistical Analyses
Statistical significance was calculated using an unpaired two-tailed Student’s
t test with unequal variance. All quantitative data are reported as the mean ±
SEM.
ACCESSION NUMBERS
Microarray data from this study can be accessed at the National Center for
Biotechnology Information Gene Expression Omnibus (NCBI GEO) under
accession number GSE18576.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, one table, and nine figures and can be found with this
article online at http://www.cell.com/cell-metabolism/supplemental/S1550-
4131(09)00336-2.
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